Skip to content
2000
Volume 24, Issue 10
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Fluorine continues to show its potential applications in drug discovery and development, as reflected by twelve drugs being fluorinated out of the fifty-five approved by the FDA in 2023. This concise review highlights the discovery of each of these fluorine-containing drugs in the past year, including its brand name, date of approval, composition, sponsors, indication, and mechanism of action. The relevant future trend is also briefly discussed.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266300245240223070242
2024-04-01
2025-01-05
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/0115680266300245240223070242
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test